Antipruritic vs. Antitumour Action of Aprepitant: A Question of Dose

Antipruritic vs. Antitumour Action of Aprepitant: A Question of Dose

Bibliographic Details
Main Authors:	Miguel Muñoz, Julio Parrilla, Marisa Rosso, Rafael Coveñas
Format:	Article
Language:	English
Published:	Society for Publication of Acta Dermato-Venereologica 2019-03-01
Series:	Acta Dermato-Venereologica
Online Access:	https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3148

Similar Items

Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy.
by: Sonja Ständer, et al.
Published: (2010-06-01)

The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer?
by: Miguel Muñoz, et al.
Published: (2020-09-01)

The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia
by: Miguel Muñoz, et al.
Published: (2020-06-01)

The Antipruritic Effect of Phototherapy
by: Franz J. Legat
Published: (2018-11-01)

Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic
by: Saadet Inan, et al.
Published: (2021-09-01)

Antipruritic Effects of Botulinum Neurotoxins
by: Parisa Gazerani
Published: (2018-03-01)

The Neuromodulatory Effect of Antipruritic Treatment of Chronic Prurigo
by: Claudia Zeidler, et al.
Published: (2019-09-01)

Antipruritic Effect of Qingpeng Ointment on the Localized Nonexudative Eczema
by: Yan Li, et al.
Published: (2019-01-01)

Investigations into the mechanism of action of antitumour quinols
by: Matthews, Charles S.
Published: (2011)

Accidental overdosing with diphenhydramine after topical application of an antipruritic lotion
by: Oen Liang Hie
Published: (1993-02-01)

Antipruritic application of ovocystatin in atopic dermatitis in dogs - preliminary study
by: Popiel Jarosław, et al.
Published: (2014-12-01)

Neurokinin-1 Receptor Antagonists against Hepatoblastoma
by: Miguel Muñoz, et al.
Published: (2019-08-01)

The effect of aprepitant for the prevention of postoperative nausea and vomiting in patients undergoing gynecologic surgery with intravenous patient controlled analgesia using fentanyl: aprepitant plus ramosetron vs ramosetron alone
by: Se-Jin Lee, et al.
Published: (2012-09-01)

Antipruritic Effects of Janus Kinase Inhibitor Tofacitinib in a Mouse Model of Psoriasis
by: Takashi Hashimoto, et al.
Published: (2019-01-01)

Curative Effect of Aprepitant Preventing CINV
by: Shasha GUAN, et al.
Published: (2018-10-01)

Aprepitant for the Treatment of Chronic Refractory Pruritus
by: Alice He, et al.
Published: (2017-01-01)

An exploration of antitumour activities and mechanisms of action of novel dimethoxyphenylbenzothiazoles
by: Stone, Erica Lynn
Published: (2006)

Antitumour and mechanism of action studies with novel cancer drugs
by: Kelland, Lloyd R.
Published: (2000)

Antipruritic Effect of Ginsenoside Rb1 and Compound K in Scratching Behavior Mouse Models
by: Yong-Wook Shin, et al.
Published: (2005-01-01)

Anti-Inflammatory and Antipruritic Effects of Luteolin from Perilla (P. frutescens L.) Leaves
by: In Hwa Jeon, et al.
Published: (2014-05-01)

Effect of Aprepitant in Patient with Gastroparesis and Related Disorders
by: Kyoungwon Jung, et al.
Published: (2018-12-01)

Chemotherapy-Induced Nausea and Vomiting: The Role of Aprepitant
by: Muath Mohammed Abu Hilal
Published: (2011-01-01)

Role of Nitric Oxide in the Antipruritic Effect of WIN 55,212-2, a Cannabinoid Agonist
by: Oyku Zeynep Gercek, et al.
Published: (2020-07-01)

Antipruritic Effects of Hypothermic and Hyperthermic Stimulation on Acupuncture-point: A Translational Research for Atopic Dermatitis
by: Kao-Sung Tsai, et al.
Published: (2015)

Drug action mechanism of platinum antitumour compounds: a DFT study.
Published: (2004)

Comparison of Pharmacokinetics of Aprepitant in Healthy Chinese and Caucasian Subjects
by: Yang MJ, et al.
Published: (2020-03-01)

Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits
by: Raghunandan Reddy Kura, et al.
Published: (2018-05-01)

Characterization and Pharmacokinetic Study of Aprepitant Solid Dispersions with Soluplus®
by: Jinwen Liu, et al.
Published: (2015-06-01)

Preparation and Characterization of Nanosuspension of Aprepitant by H96 Process
by: Sunethra Kalvakuntla, et al.
Published: (2016-03-01)

Effectiveness of aprepitant in post‐acute COVID19 syndrome
by: Rocío Reinoso‐Arija, et al.
Published: (2021-09-01)

The NK-1 Receptor Antagonist L-732,138 Induces Apoptosis and Counteracts Substance P-Related Mitogenesis in Human Melanoma Cell Lines
by: Miguel Muñoz, et al.
Published: (2010-04-01)

A randomized controlled trial of combination of peppermint, lavender, and turmeric oil for antipruritic agent in pregnant women
by: Fransisca Retno Asih, et al.
Published: (2021-03-01)

Crossover safety study of aprepitant: 2-min injection vs 30-min infusion in cancer patients receiving emetogenic chemotherapy
by: Navari RM, et al.
Published: (2019-04-01)

Antipruritic Effect of Acupuncture in Patients with Atopic Dermatitis: Feasibility Study Protocol for a Randomised, Sham-Controlled Trial
by: Yu-Kang Kim, et al.
Published: (2017-01-01)

Studies on natural antitumour cytotoxicity
by: Hassan, Z. M.
Published: (1981)

TIN-BASED ANTITUMOUR DRUGS
by: Gielen, Marcel
Published: (1994-05-01)

Investigations on new antitumour agents
by: Gate, Ernest N.
Published: (1985)

Clinical Observation of Gene Polymorphism of Olanzapine or Aprepitant in Prevention of CINV
by: Jin Y, et al.
Published: (2021-07-01)

Anti-Cancer Effect of Aprepitant on Nb4 Leukemic Cells
by: E Razani, et al.
Published: (2017-10-01)

Study of Different Crystal Habits of Aprepitant: Dissolution and Material Attributes
by: Satyajit R. Datir, et al.
Published: (2021-06-01)

Cannot write session to /tmp/vufind_sessions/sess_f91m233r9bt4t2gigu8g5ur55g